10.1007/s11682-010-9102-3 61
In a HF model with coarctation of the aorta, mice fed a high-cholesterol diet had higher TMAO levels and accelerated adverse ventricular remodeling (105)
Why It Works : Berberine influences gut health and increases GLP-1 production, supporting weight management and blood sugar balance
The L cell-derived hormone peptide YY (PYY) has a potent appetite-suppressing effect, thereby opening a potential avenue for the treatment of obesity and type 2 diabetes
If GLP-1 drugs are to be used to treat a wide range of conditions, predicting who will benefit and who may be at risk becomes one of the most important, if not the most important, challenges
Two major clinical trials are the basis for most of what's known about these medications' weight-management effects: STEP 1 (68-week randomized study, adults without diabetes): semaglutide 2.4 mg produced an average loss of roughly 15% of body weight, versus about 2.4% with placebo, alongside a reduced-calorie diet and increased physical activity